ScaleReady — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

ScaleReady, founded in 2018, commercializes the G-Rex (gas permeable rapid expansion) platform, a novel bioreactor technology for cell therapy manufacturing. Its core innovation is a gas-permeable membrane that allows for simplified, scalable cell culture without the need for frequent media exchanges or complex perfusion systems. The platform is reportedly used in the production of five commercially approved drug products and by a significant portion of US clinical trial sponsors, positioning it as a key enabling technology in the CGT space. The company operates a substantial grant program to foster adoption and advance next-generation therapies.

OncologyImmunology

Technology Platform

G-Rex (gas permeable rapid expansion) bioreactor platform for scalable cell culture. Utilizes a gas-permeable membrane, natural convection, and a diffusion boundary layer to enable high-density cell expansion without mechanical mixing or perfusion, supporting linear scalability from R&D to commercial production.

Opportunities

The rapid expansion of the cell and gene therapy market creates massive demand for scalable, cost-effective manufacturing solutions.

ScaleReady's regulatory-qualified, linearly scalable platform is uniquely positioned to capture this growth across both autologous and allogeneic therapy production.

Its established user base and grant program create a strong network effect and pipeline for future commercial expansion.

Risk Factors

Intense competition from large, established bioreactor companies and new entrants could erode market share.

The company's success is closely tied to its manufacturing partner, Wilson Wolf, creating a dependency risk.

Failure to successfully deliver and integrate its automated (Robotic G-Rex) and sensor-enabled (SMART G-Rex) systems could limit appeal as the industry standardizes on closed, automated workflows.

Competitive Landscape

ScaleReady competes in the CGT manufacturing equipment sector against major life science tools companies (e.g., Thermo Fisher/Cytiva, Sartorius, Miltenyi Biotec) offering stirred-tank, rocking, and hollow-fiber bioreactors. Its primary differentiation is the simplicity, linear scalability, and regulatory qualification of its static gas-permeable membrane platform. Competition focuses on automation, closed-system integration, and perfusion capabilities for high-density cultures.

More companies in Cell & Gene Therapy →More companies in United States →